Recent News

• 09.23.2025 - Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 09.17.2025 - Jefferies CDMO Summit 2025
• 09.16.2025 - 18th Annual Barrington Research Virtual Fall Investment Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.04.2025 - Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
• 09.03.2025 - Paul Knight
• 09.03.2025 - In Transition
• 09.02.2025 - Lifecore Biomedical to Participate in Upcoming Investor Conferences
• 08.07.2025 - Q4 and YE 2025 Earnings Webcast & Conference Call
• 08.07.2025 - Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Recent Filings

• 09.23.2025 - S-3 Registration statement under Securities Act of 1933
• 09.18.2025 - DEF 14A Other definitive proxy statements
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.18.2025 - 8-K Current report
• 08.12.2025 - 8-K Current report
• 08.12.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 08.07.2025 - 8-K Current report
• 08.07.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.07.2025 - EX-99.1 EX-99.1